Investors
Key press releases
Key upcoming events
Key corporate presentation
Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on the Euronext Growth Paris (ticker: ALCLS).
Cellectis ADS (Nasdaq)
Ticker: CLLS
$3.4200
+0.2800 (8.9172%)
- Prev. close
- 3.1400
- Volume
- 39,189
- High
- 3.5346
- Capitalization
- 155.556M
Cellectis (Euronext Growth Paris)
Ticker: ALCLS
€3.2600
+0.2660 (8.8844%)
- Prev. close
- 2.9940
- Volume
- 446,529
- High
- 3.3800
- Capitalization
- 148.250M
Covering research analysts
Barclays - Gena Wang
Citi - Yigal Nochomovitz
Goldman Sachs - Salveen Richter
Jefferies - Kelly Shi
JMP Securities - Silvan Tuerkcan
Jones Trading - Soumit Roy
Kempen - Ingrid Gafanhão
Oddo BHF - Martial Descoutures
Oppenheimer – Hartaj Singh
RW Baird - Jack Allen
Wells Fargo – Nick Abbott
William Blair – Raju Prasad
SMBC - David Dai
Cellectis contact information
Arthur Stril, Chief Business Officer
Ashley R. Robinson, LifeSci Advisors
Citibank ADR contact information
Intermediaries & Investors
US: +1 212 723 5435
UK: +44 207 500 2030
Société Générale Securities Services - Ordinary Shares contact information
Call center in English and French
Monday to Friday from 8:30am to 6pm CEST
+33 (0)2 51 85 67 89